Tehran University of Medical Sciences International Journal of Hematology-Oncology and Stem Cell Research 2008-2207 11 4 2017 10 02 262 267 EN Farzaneh Ashrafi Hematology Division of Internal Medicine Department, Isfahan University of Medical Sciences, Isfahan, Iran. AND Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran Zeinab Ebrahimi School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran Mehdi Nematbakhsh Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. AND Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, Iran 2016 05 27 2016 07 18 Background: The aim of this study was to evaluate the protective role of short hydration against nephrotoxicity induced by cisplatin (CDDP). Materials and Methods: Twenty-two patients (13 men and 9 women) under CDDP therapy were enrolled in this retrospective study between 2009 and 2014. The CDDP was given in 500 ml of isotonic solution, and before and after CDDP administration, the patients received 10mEq potassium chloride15% and 1gr magnesium sulfate in 1000 ml isotonic saline. Renal parameters were evaluated on the first day of each cycle of CDDP therapy. Results: Median cumulative CDDP dose was 465 mg/m2. Based on renal parameters, the prevalence of CDDP-induced nephrotoxicity (CIN) was 22.7%, while no hypokalemia and hypomagnesemia were observed. Conclusion:  Short hydration accompanied with potassium chloride and magnesium sulfate may decrease the risk of CIN.     https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/619 https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/619/587